Recent Investment Analysts’ Ratings Updates for STERIS (STE)

A number of research firms have changed their ratings and price targets for STERIS (NYSE: STE):

  • 11/14/2026 – STERIS was upgraded by Wall Street Zen from “buy” to “strong-buy”.
  • 11/13/2026 – STERIS was upgraded by Morgan Stanley from “overweight” to “buy”.
  • 11/13/2026 – STERIS was upgraded by Jefferies Financial Group from “hold” to “buy”. They now have a $305.00 price target on the stock, up from $232.00.
  • 11/9/2026 – STERIS was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
  • 11/6/2026 – STERIS had its price target raised by KeyCorp from $269.00 to $284.00. They now have an “overweight” rating on the stock.
  • 10/11/2026 – STERIS was downgraded by Wall Street Zen from “strong-buy” to “buy”.
  • 10/3/2026 – STERIS was upgraded by Wall Street Zen from “buy” to “strong-buy”.

STERIS Trading Down 1.8%

Shares of STE stock traded down $4.64 during mid-day trading on Thursday, hitting $254.93. 881,181 shares of the company’s stock were exchanged, compared to its average volume of 776,152. STERIS plc has a fifty-two week low of $195.14 and a fifty-two week high of $269.44. The stock has a 50-day simple moving average of $225.69 and a two-hundred day simple moving average of $224.58. The company has a quick ratio of 1.44, a current ratio of 2.05 and a debt-to-equity ratio of 0.23. The stock has a market cap of $24.76 billion, a price-to-earnings ratio of 30.24 and a beta of 0.86.

STERIS (NYSE:STE – Get Free Report) last released its earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 EPS for the quarter, beating the consensus estimate of $2.68 by $0.26. STERIS had a return on equity of 14.80% and a net margin of 13.41%. The firm had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the firm posted $2.47 earnings per share. The business’s quarterly revenue was up 8.8% compared to the same quarter last year. Equities analysts expect that STERIS plc will post 11.46 EPS for the current fiscal year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Tuesday, November 17th will be paid a dividend of $0.69 per share. The ex-dividend date of this dividend is Tuesday, November 17th. This represents a $2.76 dividend on an annualized basis and a dividend yield of 1.1%. STERIS’s dividend payout ratio is currently 32.74%.

Insider Activity

In other news, CFO Karen Burton sold 5,880 shares of the stock in a transaction dated Wednesday, November 11th. The shares were sold at an average price of $255.62, for a total transaction of $1,503,045.60. Following the transaction, the chief financial officer directly owned 12,956 shares in the company, valued at $3,311,812.72. This represents a 31.22% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Julia Madsen sold 2,046 shares of the firm’s stock in a transaction that occurred on Friday, November 13th. The stock was sold at an average price of $260.00, for a total transaction of $531,960.00. Following the completion of the sale, the vice president directly owned 10,211 shares in the company, valued at $2,654,860. This represents a 16.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 12,819 shares of company stock valued at $3,274,011 in the last 90 days. 1.12% of the stock is currently owned by insiders.

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.

Read More

Receive News & Ratings for STERIS plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS plc and related companies with MarketBeat.com's FREE daily email newsletter.